Combination of lamivudine and adefovir dipivoxil for treatment of chronic hepatitis B.
Phase of Trial: Phase II
Latest Information Update: 24 Jul 2014
At a glance
- Drugs Adefovir (Primary) ; Lamivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 03 Apr 2013 Planned end date changed from 1 Sep 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 18 May 2010 Planned end date changed from 1 Sep 2006 to 1 Sep 2012 as reported by ClinicalTrials.gov.